French artificial heart maker Carmat targets break-even in 2027
By Dina Kartit (Reuters) -French artificial heart maker Carmat expects to break-even in 2027, it said on Monday, as it gradually resumes implants and faces strong demand in Europe ahead of its commercial launch in the United States. The Aeson implant maker, which targets a U.S. launch in 2026, plans to lift its production to …
French artificial heart maker Carmat targets break-even in 2027 Read More »










